Good Candidates Athletes recovering from tendon/ligament injuries Achilles tendonitis, rotator cuff issues, tennis elbow, patellar tendinopathy
Tirzepatide as an alternative Tirzepatide (Mounjaro, Zepbound) is a dual GIP/GLP-1 agonist that some research suggests may preserve muscle better than semaglutide
The most common side effects for Zepbound (tirzepatide) include: Constipation Decreased appetite Diarrhea Fatigue Gastroesophageal reflux disease Hair loss Indigestion Injection-site reactions Nausea Stomach pain Vomiting In tirzepatides clinical trials, researchers noted that when doses increased, side effects, like nausea and diarrhea occurred
2023) and is widely recognized as a multifactorial disorder resulting from complex interactions between genetic and environmental factors (Lord et al
For some people, their use can interact with an existing or developing eating disorder in ways that are worth understanding
in SUSTAIN-6, 1 mg of semaglutide lowered SBP more than the 0.5 mg dose [15]